Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00064025
Status:
COMPLETED
Last Update Posted:
2016-04-11
First Post:
2003-07-08
Brief Title:
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
Sponsor:
Gynecologic Oncology Group
Organization:
GOG Foundation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Uterine Corpus Cancer |
| Endometrial Adenocarcinoma |
| Endometrial Adenosquamous Carcinoma |
| Endometrial Endometrioid Adenocarcinoma Variant With Squamous Differentiation |
| Recurrent Uterine Corpus Carcinoma |
| Stage I Uterine Corpus Cancer |
| Stage II Uterine Corpus Cancer |
| Stage III Uterine Corpus Cancer |
Keywords: